Stay updated on Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedResults data were posted, including radiographic RECIST responses, pathologic response, adverse events, and survival outcomes with timing details. The update also references the associated study documents and submission dates.SummaryDifference3%

- Check31 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the study page.SummaryDifference0.1%

- Check59 days agoChange DetectedA minor site revision was issued (Revision: v3.4.2), replacing the previous v3.4.1 and removing the government funding lapse notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange DetectedAdded a site-wide government funding notice and upgraded from v3.4.0 to v3.4.1; this does not affect the study content, endpoints, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedAdded a glossary display and status indicators (Results Submitted, Last Update Submitted that Met QC Criteria, Last Update Posted) and updated the revision to v3.4.0, while removing older indicators (No Results Posted, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4).SummaryDifference0.3%

- Check88 days agoChange DetectedThe page shows a revision label updated from v3.3.3 to v3.3.4. No substantive changes to the study details or page content are evident; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.